Alzheimer disease and cerebrovascular pathology: an update
The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
Recent epidemiological and clinico-pathologic data suggest overlaps between Alzheimer disease (AD) and cerebrovascular lesions that may magnify the effect of mild AD pathology and promote progression of cognitive decline or even may precede neuronal damage and dementia. Vascular pathology in the aging brain and in AD includes: 1. cerebral amyloid angiopathy (CAA) with an incidence of 82-98% often associated with ApoE epsilon 2 and causing a) cerebral mass hemorrhages (around 70%, mainly in the frontal and parietal lobes), b) multiple or recurrent microhemorrhages (15%), and c) ischemic (micro-)infarcts or lacunes (around 20%). The frequency of these lesions increases with the severity of CAA and shows no correlation with that of senile amyloid plaques. CAA, significantly more frequent in patients with cerebral hemorrhages or infarcts than in aged controls, is an important risk factor for cerebrovascular lesions in AD. 2. Microvascular changes with decreased density and structural abnormalities causing regional metabolic and blood-brain barrier dysfunctions with ensuing neuronal damage. In large autopsy series of demented aged subjects, around 80% show Alzheimer type pathology, 20-40% with additional, often minor vascular lesions, 7-10% "pure" vascular dementia, and 3-5% "mixed" dementia (combination of AD and vascular encephalopathy). AD cases with additional minor cerebrovascular lesions have significantly more frequent histories of hypertension or infarcts than "pure" AD patients. Vascular lesions in AD include cortical microinfarcts, subcortical lacunes, white matter lesions / leukoencephalopathy, small hemorrhages and corticosubcortical infarcts, while in mixed type dementia multiple larger or hemispheral infarcts are more frequent. Small infarcts in AD patients have no essential impact on global cognitive decline which mainly depends on the severity of Alzheimer pathology, but in early stage of AD they may influence and promote the development of dementia. Recent studies showed lower density of plaques and tangles in brains with cerebrovascular lesions, and similar severity of dementia was related to fewer AD lesions in brains with than in those without small vascular lesions. Further studies will help to elucidate the risk factors and impact of cerebrovascular lesions on the development and progression of dementia in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CAA appears in ≈10% to 30% of unselected brain autopsies and 80% to 100% when in the presence of accompanying Alzheimer disease.136”
In the citing paper
“which virtually all individuals with AD and about a third of aged cognitively normal individuals have) [68, 179]”
From Alzheimer's disease: experimental models and reality (2017) · cites this paper as [68]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 2×
“of currently used neuropathological diagnostic criteria for AD (Mirra et al., 1991; Braak and Braak, 1991; Hyman, 1998).”
BackgroundMethodMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084 · cited 2×
“…to many authors, MD should be diagnosed only if there are sufficient vascular and degenerative lesions to make each diagnosis independently (Tomlinson et al., 1970; Boller et al., 1989; Erkinjuntti, 1988; Jellinger et al., 1990; Mirra et al., 1991), while others suggest the diagnosis of AD…”
Background15-year longitudinal study of blood pressure and dementia
Skoog, I., Nilsson, L., Persson, G., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L.-A., Odén, A., & Svanborg, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90608-x · Cited by 1,726 · cited 1×
“An association between hypertension and AD has been reported in several prospective studies (Skoog et al., 1993, 1996; Hofman et al., 1997; Skoog, 2000; Launer et al., 2000; Meyer et al., 2000; Schmidt et al., 2000; Kivipelto et al., 2001).”
BackgroundKivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618 · cited 2×
“An association between hypertension and AD has been reported in several prospective studies (Skoog et al., 1993, 1996; Hofman et al., 1997; Skoog, 2000; Launer et al., 2000; Meyer et al., 2000; Schmidt et al., 2000; Kivipelto et al., 2001).”
Background(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338 · cited 2×
“that came to autopsy, but most patients had mixed disease without clear thresholds of pathological features that predicted dementia (Esiri et al., 2001).”
BackgroundChui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992) · Neurology · doi:10.1212/wnl.42.3.473 · Cited by 1,201 · cited 2×
“, 1991), while in the ADDTC criteria (Chui et al., 1992), a second cerebrovascular disorder in addition to AD must be shown to”
BackgroundCerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102 · cited 6×
“…vessels (Claudio, 1996; Farkas et al., 2000) with increase of collagen IV (Kalaria and Pax, 1995) and breakdown of the BBB are considered important factors for disturbances of cerebral metabolism, reduced cerebral blood flow and neural metabolic changes (Shi et al., 2000; Farkas and Luiten, 2001).”
BackgroundInfluentialHofman, A., Ott, A., Breteler, M. M., Bots, M. L., Slooter, A. J., van Harskamp, F., van Duijn, C. N., Van Broeckhoven, C., & Grobbee, D. E. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09328-2 · Cited by 1,062 · cited 4×
“Hypertension and hypercholesterinemia, independent of the ApoE genotype have been shown to be risk factors for AD (Hofman et al., 1997; Skoog et al., 1999).”
BackgroundInfluentialClinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria
Knudsen, K. A., Rosand, J., Karluk, D., & Greenberg, S. M. (2001) · Neurology · doi:10.1212/wnl.56.4.537 · Cited by 1,015
Midlife blood pressure and dementia: the Honolulu–Asia aging study☆
Launer, L. J., Ross, G. W., Petrovitch, H., Masaki, K., Foley, D., White, L. R., & Havlik, R. J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00096-8 · Cited by 1,008 · cited 2×
“An association between hypertension and AD has been reported in several prospective studies (Skoog et al., 1993, 1996; Hofman et al., 1997; Skoog, 2000; Launer et al., 2000; Meyer et al., 2000; Schmidt et al., 2000; Kivipelto et al., 2001).”
BackgroundThe incidence of dementia: A meta-analysis
Jorm, A. F., & Jolley, D. (1998) · Neurology · doi:10.1212/wnl.51.3.728 · Cited by 903
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-351_2 · Cited by 860
Risk of Dementia among Persons with Diabetes Mellitus: A Population-based Cohort Study
Leibson, C. L., Rocca, W. A., Hanson, V. A., Cha, R., Kokmen, E., O'Brien, P. C., & Palumbo, P. J. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009106 · Cited by 700 · cited 1×
“Leibson et al. (1997), in a large retrospective cohort study found adult onset diabetes was a major risk factor for AD and non-AD dementia and a recent study reporting an adjusted relative risk of AD among persons with compared with those without diabetes of 1.3, indicating a modest relation…”
ResultInfluentialA Population-Based Study of Dementia in 85-Year-Olds
Skoog, I., Nilsson, L., Palmertz, B., Andreasson, L.-A., & Svanborg, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280301 · Cited by 696
Diabetes Mellitus and Risk of Alzheimer's Disease and Dementia with Stroke in a Multiethnic Cohort
Luchsinger, J. A. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.7.635 · Cited by 682 · cited 2×
“3, indicating a modest relation between both disorders (Luchsinger et al., 2001).”
BackgroundResultInfluentialWeller, R. O., Massey, A., Newman, T. A., Hutchings, M., Kuo, Y.-M., & Roher, A. E. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65616-7 · Cited by 679 · cited 2×
“-amyloid may accumulate as the result of reduced clearance via the interstitital drainage channels (Weller et al., 1998) or microglia may take up extracellular A of neuronal origin and deposit it in the vascular lumen, such triggering SMC production of more A .”
BackgroundBrain Infarction and the Clinical Expression of Alzheimer Disease-Reply
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550020046024 · Cited by 674 · cited 6×
“…with AD remains unclear, but recent studies suggest that a concomitant cerebral infarction may aggravate the severity of dementia in AD patients (Snowdon et al., 1997; Heyman et al., 1998) or may magnify the effect of mild AD pathological features and result in the earlier expression of…”
BackgroundResultInfluentialCerebral White Matter Is Highly Vulnerable to Ischemia
Pantoni, L., Garcia, J. H., & Gutierrez, J. A. (1996) · Stroke · doi:10.1161/01.str.27.9.1641 · Cited by 608 · cited 1×
“The cerebral white matter is more vulnerable to ischemia as previously thought (Pantoni et al., 1996).”
BackgroundGrabowski, T. J., Cho, H. S., Vonsattel, J. P. G., Rebeck, G. W., & Greenberg, S. M. (2001) · Annals of Neurology · doi:10.1002/ana.1009 · Cited by 523
The role of cerebral ischemia in Alzheimer’s disease
Kalaria, R. N. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00125-1 · Cited by 521 · cited 1×
“…and synergistically to cognitive decline related to Alzheimer pathology (Buée et al., 1997; Shi et al., 2000; De la Torre and Stefano, 2000; Kalaria, 2000; Skoog, 2000; Kudo et al., 2000; Schmidt et al., 2000; Farkas and Lutten, 2001; Brown et al., 2001), but the role of cerebrovascular…”
BackgroundCerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease
Esiri, M. M., Nagy, Z., Smith, M. Z., Barnetson, L., & Smith, A. D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02355-7 · Cited by 493 · cited 4×
“two types of lesion, each of them alone being insufficient to account for dementia which, however, arises from their association (Cummings and Benson, 1989; Snowdon et al., 1997; Esiri et al., 1999; Lee et al., 2000).”
BackgroundResultInfluentialApolipoprotein E and Alzheimer's disease
Strittmatter, W. J., & Roses, A. D. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.000413 · Cited by 477
Overlap Between Pathology of Alzheimer Disease and Vascular Dementia
Kalaria, R. N., & Ballard, C. (1999) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199912003-00017 · Cited by 470 · cited 13×
“These data suggest that, although CAA is an independent risk factor of WML in AD, its role appears to be limited in comparison to that of wall thickening of WM microvessels due to FH which may or may not be associated with CAA, thus indicating the pathogenetic heterogeneity of WML in AD (Tomimoto et al., 1999).”
BackgroundInfluentialClinical-Neuropathological Correlations in Alzheimer's Disease and Related Dementias
Galasko, D., Hansen, L. A., Katzman, R., Wiederholt, W., Masliah, E., Terry, R., Hill, L. R., Lessin, P., & Thal, L. J. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540210060013 · Cited by 409 · cited 1×
“Since strokes are common in elderly subjects and increase with age (Markesbery, 1991; Skoog et al., 1993), in most clinicopathologic series of demented patients, 18 to 60% of all have AD with cerebrovascular lesions (Mirra et al., 1991; Galasko et al., 1994; Gearing et al., 1995; Jellinger, 2000).”
BackgroundGearing, M., Mirra, S. S., Hedreen, J. C., Sumi, S. M., Hansen, L. A., & Heyman, A. (1995) · Neurology · doi:10.1212/wnl.45.3.461 · Cited by 380 · cited 1×
“Since strokes are common in elderly subjects and increase with age (Markesbery, 1991; Skoog et al., 1993), in most clinicopathologic series of demented patients, 18 to 60% of all have AD with cerebrovascular lesions (Mirra et al., 1991; Galasko et al., 1994; Gearing et al., 1995; Jellinger, 2000).”
BackgroundHoltzman, D. M., Bales, K. R., Wu, S., Bhat, P., Parsadanian, M., Fagan, A. M., Chang, L. K., Sun, Y., & Paul, S. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6179 · Cited by 349
MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease
Mungas, D., Jagust, W. J., Reed, B. R., Kramer, J. H., Weiner, M. W., Schuff, N., Norman, D., Mack, W. J., Willis, L., & Chui, H. C. (2001) · Neurology · doi:10.1212/wnl.57.12.2229 · Cited by 341
Cerebral vessels in ageing and Alzheimer's disease
Kalaria, R. N. (1996) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00116-7 · Cited by 336
Bu�e, L., Hof, P. R., Bouras, C., Delacourte, A., Perl, D. P., Morrison, J. H., & Fillit, H. M. (1994) · Acta Neuropathologica · doi:10.1007/bf00294173 · Cited by 334
Desgranges, B. (1998) · Brain · doi:10.1093/brain/121.4.611 · Cited by 329 · cited 2×
“The histological change in the density of glucose transporter (Mooradian et al., 1997) is confirmed by in vivo imaging studies, and is only one of the many vascular biochemical changes associated with AD (Simpson et al., 1994; Desgranges et al., 1998).”
BackgroundPeriventricular venous collagenosis: association with leukoaraiosis.
Moody, D. M., Brown, W. R., Challa, V. R., & Anderson, R. L. (1995) · Radiology · doi:10.1148/radiology.194.2.7824728 · Cited by 309 · cited 1×
“…twining, and braiding of vessels (Boström and Hassler, 1966), periventricular venous collagenosis resulting in narrowed lumina and even occlusion (Moody et al., 1995), and vascular tortuosity often associated with white matter lesions (WML) (Brown et al., 2000), In addition, there are…”
BackgroundEvidence that Alzheimer’s disease is a microvascular disorder: the role of constitutive nitric oxide
de la Torre, J. C., & Stefano, G. B. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00043-6 · Cited by 308 · cited 1×
“…contribute to its pathogenesis and synergistically to cognitive decline related to Alzheimer pathology (Buée et al., 1997; Shi et al., 2000; De la Torre and Stefano, 2000; Kalaria, 2000; Skoog, 2000; Kudo et al., 2000; Schmidt et al., 2000; Farkas and Lutten, 2001; Brown et al., 2001), but the…”
BackgroundNeuropathologic Substrates of Ischemic Vascular Dementia
Vinters, H. V., Ellis, W. G., Zarow, C., Zaias, B. W., Jagust, W. J., Mack, W. J., & Chui, H. C. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.11.931 · Cited by 304 · cited 2×
“…of the perforating arteries related to chronic hypertension and subsequent chronic cerebral hypoperfusion (Furuta et al., 1991; Wahlund et al., 1994; Wakita et al., 1994; Fazekas et al., 1998) but also can occur in association with CAA (Gray et al., 1985; Munoz et al., 1995; Vinters et al., 2000).”
BackgroundHigh frequency of apolipoprotein E ϵ2 Allele in hemorrhage due to cerebral amyloid angiopathy
Nicoll, J. A. R., Burnett, C., Love, S., Graham, D. I., Dewar, D., Ironside, J. W., Stewart, J., & Vinters, H. V. (1997) · Annals of Neurology · doi:10.1002/ana.410410607 · Cited by 284 · cited 2×
“, 1996), whereas the ε2 allele has been linked to greater risk of CAA-associated vasculopathy and CNS hemorrhage (Nicoll et al., 1997; Greenberg et al., 1998; McCarron and Nicoll, 2000; Nicoll and McCarron, 2001).”
BackgroundO’Brien, K. D., Olin, K. L., Alpers, C. E., Chiu, W., Ferguson, M., Hudkins, K., Wight, T. N., & Chait, A. (1998) · Circulation · doi:10.1161/01.cir.98.6.519 · Cited by 271 · cited 3×
“It is surprising, however, that the connection between ApoEε4 and cerebrovascular compromises had not been established given the involvement of ApoE genotype in arteriosclerosis and cardiac infarcts (Biggart et al., 1998; O’Brien et al., 1998; Snowdon et al., 1997).”
BackgroundAssociation of apolipoprotein E ϵ2 and vasculopathy in cerebral amyloid angiopathy
Greenberg, S. M., Vonsattel, J.-P. G., Segal, A. Z., Chiu, R. I., Clatworthy, A. E., Liao, A., Hyman, B. T., & Rebeck, G. W. (1998) · Neurology · doi:10.1212/wnl.50.4.961 · Cited by 267 · cited 1×
“…levels of cerebrovascular amyloid deposition and CNS hemorrhage (Olichney et al., 1996), whereas the ε2 allele has been linked to greater risk of CAA-associated vasculopathy and CNS hemorrhage (Nicoll et al., 1997; Greenberg et al., 1998; McCarron and Nicoll, 2000; Nicoll and McCarron, 2001).”
BackgroundClinicopathological analysis of dementia disorders in the elderly
Jellinger, K., Danielczyk, W., Fischer, P., & Gabriel, E. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90072-u · Cited by 243 · cited 1×
“…sufficient vascular and degenerative lesions to make each diagnosis independently (Tomlinson et al., 1970; Boller et al., 1989; Erkinjuntti, 1988; Jellinger et al., 1990; Mirra et al., 1991), while others suggest the diagnosis of AD in addition to ischemicvascular lesions (Mendez et al., 1992),…”
BackgroundSelf-citationCoronary Artery Disease, Hypertension, ApoE, and Cholesterol: A Link to Alzheimer's Disease?
SPARKS, D. L. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48466.x · Cited by 243
Cerebral amyloid angiopathy: Prospects for clinical diagnosis and treatment
Greenberg, S. M. (1998) · Neurology · doi:10.1212/wnl.51.3.690 · Cited by 243
Erkinjuntti, T., Haltia, M., Palo, J., Sulkava, R., & Paetau, A. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.8.1037 · Cited by 229 · cited 1×
“Erkinjuntti et al. (1988), in a small cohort of demented patients reported a mean tissue loss of 39ml with a range of 1 to 229ml.”
BackgroundThe Effects of Additional Pathology on the Cognitive Deficit in Alzheimer Disease
NAGY, Z., ESIRI, M. M., JOBST, K. A., MORRIS, J. H., -F. KING, E. M., MCDONALD, B., JOACHIM, C., LITCHFIELD, S., BARNETSON, L., & SMITH, A. D. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199702000-00007 · Cited by 218 · cited 2×
“result in the earlier expression of dementia (Nagy et al., 1997).”
BackgroundSavaskan, E., Hock, C., Olivieri, G., Bruttel, S., Rosenberg, C., Hulette, C., & Müller-Spahn, F. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00259-1 · Cited by 217 · cited 2×
“giotensin II, and AT1 receptor in cortical neurons and around some cortical vessels in AD, also pointing to an underlying microvascular pathology in the process of neurodegeneration in AD (Savaskan et al., 2001).”
BackgroundClaudio, L. (1995) · Acta Neuropathologica · doi:10.1007/s004010050386 · Cited by 210 · cited 4×
“An additional sign of disrupted BBB in AD may be the compromised morphology of tight junctions (Claudio, 1996), whereas data on changes of microvascular pericytes are conflicting (Farkas et al., 2000).”
BackgroundInfluentialTomimoto, H., Akiguchi, I., Suenaga, T., Nishimura, M., Wakita, H., Nakamura, S., & Kimura, J. (1996) · Stroke · doi:10.1161/01.str.27.11.2069 · Cited by 204 · cited 1×
“Although the disruption of the BBB in AD is less intense than in ischemic CVD (Steward et al., 1992; Tomimoto et al., 1996; Akiguchi et al., 1998), in may contribute to damage of the surrounding tissue, in particular of the white matter.”
BackgroundGLUT-1 Expression in the Cerebra of Patients with Alzheimer’s Disease
Mooradian, A. D., Chung, H. C., & Shah, G. N. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00111-5 · Cited by 199 · cited 2×
“The histological change in the density of glucose transporter (Mooradian et al., 1997) is confirmed by in vivo imaging studies, and is only one of the many”
BackgroundRate of Stroke Recurrence in Patients With Primary Intracerebral Hemorrhage
Hill, M. D., Silver, F. L., Austin, P. C., & Tu, J. V. (2000) · Stroke · doi:10.1161/01.str.31.1.123 · Cited by 185 · cited 2×
“Several recent studies described multiple simultaneous intracerebral hemorrhage associated with CAA (Hill et al., 2000; Maurino et al., 2001).”
BackgroundSPARKS, D. L., KUO, Y., ROHER, A., MARTIN, T., & LUKAS, R. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06384.x · Cited by 178
Vascular Factors and Alzheimer Disease
Skoog, I., Kalaria, R. N., & Breteler, M. M. B. (1999) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199912003-00016 · Cited by 177 · cited 2×
“Hypertension and hypercholesterinemia, independent of the ApoE genotype have been shown to be risk factors for AD (Hofman et al., 1997; Skoog et al., 1999).”
BackgroundCerebral Microvascular Alterations in Aging, Leukoaraiosis, and Alzheimer's Diseasea
Moody, D. M., Brown, W. R., Challa, V. R., Ghazi-Birry, H. S., & Reboussin, D. M. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48464.x · Cited by 174
A quantitative MRI study of vascular dementia
Liu, C. K., Miller, B. L., Cummings, J. L., Mehringer, C. M., Goldberg, M. A., Howng, S. L., & Benson, D. F. (1992) · Neurology · doi:10.1212/wnl.42.1.138 · Cited by 172 · cited 2×
“More recent studies have considered infacts with a volume of 10 to 50qcm to be significant (Liu et al., 1992; Del Ser et al., 1990), while other studies of AD patients with concomitant CVD features have included infarcts of any size (Bowler et al., 1997).”
BackgroundIncreased collagen content of cerebral microvessels in Alzheimer's disease
Kalaria, R. N., & Pax, A. B. (1995) · Brain Research · doi:10.1016/0006-8993(95)01250-8 · Cited by 171 · cited 2×
“, 2000) with increase of collagen IV (Kalaria and Pax, 1995) and breakdown of the BBB are”
BackgroundCorder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., Tanzi, R. E., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1323 · Cited by 169 · cited 1×
“The ApoEε4 allele is an important genetic risk factor for sporadic AD, while ApoEε2 may be protective (Strittmacher et al., 1996; Corder et al., 1995).”
BackgroundAliev, G., Smith, M. A., Seyidova, D., Neal, M. L., Lamb, B. T., Nunomura, A., Gasimov, E. K., Vinters, H. V., Perry, G., LaManna, J. C., et al. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00419.x · Cited by 168 · cited 2×
“these noxious factors, despite extensive experimental data needs further elucidation (Farkas and Luiten, 2001; Aliev et al., 2002).”
BackgroundNatté, R., Maat‐Schieman, M. L. C., Haan, J., Bornebroek, M., Roos, R. A. C., & Van Duinen, S. G. (2001) · Annals of Neurology · doi:10.1002/ana.10040 · Cited by 166 · cited 1×
“Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with CAA but is independent of neuro-fibrillary tangles and plaques (Natté et al., 2001).”
BackgroundDiagnosis of dementia: Clinicopathologic correlations
Boiler, F., Lopez, O. L., & Moossy, J. (1989) · Neurology · doi:10.1212/wnl.39.1.76 · Cited by 159
Leys, D., Pruvo, J. P., Parent, M., Vermersch, P., Soetaert, G., Steinling, M., Delacourte, A., Defossez, A., Rapoport, A., & Clarisse, J. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.1.46 · Cited by 159 · cited 2×
“In contrast, it remains unclear whether the WML in AD are caused by Wallerian degeneration (Leys et al., 1991) or by cerebral hypoperfusion caused by fibrohyalinosis (FH) similar to that found in CML (Brun and Englund, 1985; Ferrer et al., 1990), denervation microangiopathy (Scheibel et al., 1987)…”
BackgroundResultClinically Diagnosed Alzheimer Disease
Mendez, M. F., Mastri, A. R., Sung, J. H., & Frey, W. H. (1992) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199205000-00004 · Cited by 153 · cited 2×
“, 1991), while others suggest the diagnosis of AD in addition to ischemicvascular lesions (Mendez et al., 1992), or believe in an interaction between the”
BackgroundCadavid, D., Mena, H., Koeller, K. K., & Frommelt, R. A. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.9.768 · Cited by 151 · cited 1×
“CAA in cases with cerebral infarcts mainly involved large and less frequently small cortical vessels, while A deposits in meningeal vessels were not different between infarct and control groups (Cadavid et al., 2000).”
BackgroundA morphometric study of the blood-brain barrier in Alzheimer's disease.
Stewart, P. A., Hayakawa, K., Akers, M.-A., & Vinters, H. V. (1992) · PubMed · Cited by 148
Link between heart disease, cholesterol, and Alzheimer's disease: A review
Sparks, D. L., Martin, T. A., Gross, D. R., & Hunsaker, J. C. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20000815)50:4<287::aid-jemt7>3.0.co;2-l · Cited by 147
Progression of Cerebral Amyloid Angiopathy: Accumulation of Amyloid-ß40 in Affected Vessels
Alonzo, N. C., Hyman, B. T., Rebeck, G. W., & Greenberg, S. M. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199804000-00008 · Cited by 146 · cited 2×
“…-40 intracellularly which aggregates extracellularly into fibrils that induce further SMC degeneration. in the course of which complete replacement of medial SMCs by fibrillary amyloid may occur, with ensuing blood vessel rupture and hemodynamic changes (Coria and Rubio, 1996; Alonzo et al., 1998).”
BackgroundEffects of Subcortical Cerebral Infarction on Cortical Glucose Metabolism and Cognitive Function
Kwan, L. T., Reed, B., Eberling, J. L., Schuff, N. W., Tanabe, J., Norman, D. M., Weiner, M. W., & Jagust, W. J. (1999) · Archives of Neurology · doi:10.1001/archneur.56.7.809 · Cited by 140 · cited 2×
“tabolism particularly in frontal areas which is related to the cognitive status (Kwan et al., 1999).”
BackgroundNeurofibrillary Pathology in Transgenic Mice Overexpressing V717F β-Amyloid Precursor Protein
Masliah, E., Sisk, A., Mallory, M. E., & Games, D. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.4.357 · Cited by 135 · cited 2×
“…evidence from transgenic models now indicates that mutation in the A domain of neuronal APP may predispose to a vascular pathology, whereas mutations outside the A domain lead to more neuronal pathology (Emilien et al., 2000; Grabowski et al., 2000; Holtzman et al., 2000; Masliah et al., 2001).”
Backgrounddel Ser, T., Bermejo, F., Portera, A., Arredondo, J., Bouras, C., & Constantinidis, J. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90052-o · Cited by 131 · cited 6×
“More recent studies have considered infacts with a volume of 10 to 50qcm to be significant (Liu et al., 1992; Del Ser et al., 1990), while other studies of AD patients with concomitant CVD features have included infarcts of any size (Bowler et al., 1997).”
BackgroundInfluentialKozachuk, W. E., DeCarli, C., Schapiro, M. B., Wagner, E. E., Rapoport, S. I., & Horwitz, B. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120050009 · Cited by 126 · cited 1×
“…in white matter lesions in AD White matter lesions (WML) are frequently found in AD and may or may not be correlated with cognitive decline (De la Monte, 1989; Kozachuk et al., 1990; Lopez et al., 1992; Wahlund et al., 1994; Amar et al., 1996; Kapeller and Schmidt, 1998; De Groot et al., 1998).”
BackgroundOlichney, J., Hansen, L. A., Hofstetter, C. R., Lee, J. H., Katzman, R., & Thal, L. J. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.869 · Cited by 125
Cerebrovascular Hypoperfusion: A Risk Factor for Alzheimer's Disease?
de Jong, G. I., de Vos, R. A. I., Steur, E. N. H. J., & Luiten, P. G. M. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48461.x · Cited by 120 · cited 1×
“The lack of correlation between the stage of the disease (Braak I-VI) and the aberrations of cerebral microvessels suggested that the changes in vasculature are not a consequence of AD pathology (De Jong et al., 1997), although the progress of AD may provoke early cerebrovascular damage.”
BackgroundCardiovascular and Other Risk Factors for Alzheimer's Disease and Vascular Dementia
Meyer, J. S., Rauch, G. M., Rauch, R. A., Haque, A., & CRAWFORD, K. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06393.x · Cited by 113 · cited 2×
“An association between hypertension and AD has been reported in several prospective studies (Skoog et al., 1993, 1996; Hofman et al., 1997; Skoog, 2000; Launer et al., 2000; Meyer et al., 2000; Schmidt et al., 2000; Kivipelto et al., 2001).”
BackgroundDonahue, J. E., Berzin, T. M., Rafii, M. S., Glass, D. J., Yancopoulos, G. D., Fallon, J. R., & Stopa, E. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6468 · Cited by 112
Apolipoprotein E Genotype and Cerebral Amyloid Angiopathy‐related Hemorrhage
McCarron, M. O., & Nicoll, J. A. R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06366.x · Cited by 110 · cited 2×
“, 1996), whereas the ε2 allele has been linked to greater risk of CAA-associated vasculopathy and CNS hemorrhage (Nicoll et al., 1997; Greenberg et al., 1998; McCarron and Nicoll, 2000; Nicoll and McCarron, 2001).”
BackgroundNeuropathological background of twenty-seven centenarian brains
Mizutani, T., & Shimada, H. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90047-o · Cited by 109
Vascular risk factors in dementia
Schmidt, R., Schmidt, H., & Fazekas, F. (2000) · Journal of Neurology · doi:10.1007/s004150050021 · Cited by 105 · cited 3×
“An association between hypertension and AD has been reported in several prospective studies (Skoog et al., 1993, 1996; Hofman et al., 1997; Skoog, 2000; Launer et al., 2000; Meyer et al., 2000; Schmidt et al., 2000; Kivipelto et al., 2001).”
BackgroundCerebrovascular Pathology in Alzheimer's Disease and Leukoaraiosis
Brown, W. R., Moody, D. M., Thore, C. R., & Challa, V. R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06348.x · Cited by 102 · cited 9×
“These data suggest that, although CAA is an independent risk factor of WML in AD, its role appears to be limited in comparison to that of wall thickening of WM microvessels due to FH which may or may not be associated with CAA, thus indicating the pathogenetic heterogeneity of WML in AD (Tomimoto et al., 1999).”
BackgroundInfluentialLee, J. H., Olichney, J., Hansen, L. A., Hofstetter, C. R., & Thal, L. J. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1474 · Cited by 99 · cited 4×
“two types of lesion, each of them alone being insufficient to account for dementia which, however, arises from their association (Cummings and Benson, 1989; Snowdon et al., 1997; Esiri et al., 1999; Lee et al., 2000).”
BackgroundResultInfluentialFazekas, F., Schmidt, R., Kleinert, R., Kapeller, P., Roob, G., & Flooh, E. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_4 · Cited by 96 · cited 2×
“…of the perforating arteries related to chronic hypertension and subsequent chronic cerebral hypoperfusion (Furuta et al., 1991; Wahlund et al., 1994; Wakita et al., 1994; Fazekas et al., 1998) but also can occur in association with CAA (Gray et al., 1985; Munoz et al., 1995; Vinters et al., 2000).”
BackgroundVascular abnormalities: the insidious pathogenesis of Alzheimer’s disease☆
Shi, J., Perry, G. L., Smith, M. A., & Friedland, R. P. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00119-6 · Cited by 95 · cited 4×
“…vessels (Claudio, 1996; Farkas et al., 2000) with increase of collagen IV (Kalaria and Pax, 1995) and breakdown of the BBB are considered important factors for disturbances of cerebral metabolism, reduced cerebral blood flow and neural metabolic changes (Shi et al., 2000; Farkas and Luiten, 2001).”
BackgroundInfluentialPassant, U., Warkentin, S., & Gustafson, L. (1997) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199703)12:3<395::aid-gps527>3.0.co;2-# · Cited by 94
Farkas, E., de Jong, G. I., Apró, E., de Vos, R. A. I., Steur, E. N. H. J., & Luiten, P. G. M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06352.x · Cited by 77 · cited 5×
“…of the basement membrane (Donahue et al., 1999) or, in contrast, thickening of the basement membrane of cortical vessels (Claudio, 1996; Farkas et al., 2000) with increase of collagen IV (Kalaria and Pax, 1995) and breakdown of the BBB are considered important factors for disturbances…”
BackgroundInfluentialDENERVATION MICROANGIOPATHY IN SENILE DEMENTIA, ALZHEIMER TYPE
Scheibel, A. B., Duong, T., & Tomiyasu, U. (1987) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198701000-00004 · Cited by 75
Dermaut, B. (2001) · Brain · doi:10.1093/brain/124.12.2383 · Cited by 74 · cited 1×
“Studies in early onset familial AD caused by a novel presenilin 1 mutation showed that CAA, in the absence of strokes, induced strong local dystrophic and inflammatory reactions, indicating that CAA may contribute considerably to the progression of neuro-degeneration in AD (Dermaut et al., 2001).”
BackgroundVascular aspects in Alzheimer’s disease
Skoog, I. (2000) · Advances in Dementia Research · doi:10.1007/978-3-7091-6781-6_6 · Cited by 71 · cited 5×
“Hypertension is also known to cause breakdown of the BBB integrity which may consequently cause cerebral edema and induce systemic elements into the brain (Skoog, 2000).”
BackgroundInfluentialCognitive correlates of cerebral white matter changes
de Groot, J. C., de Leeuw, F., & Breteler, M. M. B. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_5 · Cited by 67 · cited 1×
“…in white matter lesions in AD White matter lesions (WML) are frequently found in AD and may or may not be correlated with cognitive decline (De la Monte, 1989; Kozachuk et al., 1990; Lopez et al., 1992; Wahlund et al., 1994; Amar et al., 1996; Kapeller and Schmidt, 1998; De Groot et al., 1998).”
BackgroundCerebrovascular muscle atrophy is a feature of Alzheimer's disease
Perry, G. L., Smith, M. A., McCann, C. E., Siedlak, S. L., Jones, P. K., & Friedland, R. P. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00006-7 · Cited by 67 · cited 2×
“Ultrastructural changes in capillary walls with atrophy of SMCs, attenuation of capillary endothelium (Perry et al., 1998), thinning and fragmentation of the basement membrane (Donahue et al., 1999) or, in contrast, thickening of the basement membrane of cortical vessels (Claudio, 1996; Farkas et…”
BackgroundAre cerebrovascular factors involved in Alzheimer’s disease?
Kudo, T., Imaizumi, K., Tanimukai, H., Katayama, T., Sato, N., Nakamura, Y., Tanaka, T., Kashiwagi, Y., Jinno, Y., Tohyama, M., et al. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00129-9 · Cited by 66 · cited 1×
“…to cognitive decline related to Alzheimer pathology (Buée et al., 1997; Shi et al., 2000; De la Torre and Stefano, 2000; Kalaria, 2000; Skoog, 2000; Kudo et al., 2000; Schmidt et al., 2000; Farkas and Lutten, 2001; Brown et al., 2001), but the role of cerebrovascular pathology in AD is a matter of…”
BackgroundGiannakopoulos, P., Hof, P. R., Surini, M., Michel, J., & Bouras, C. (1993) · Acta Neuropathologica · doi:10.1007/bf00334669 · Cited by 66
Binswanger's disease is not a single entity
Loeb, C. (2000) · Neurological Sciences · doi:10.1007/s100720070048 · Cited by 65 · cited 5×
“In contrast, it remains unclear whether the WML in AD are caused by Wallerian degeneration (Leys et al., 1991) or by cerebral hypoperfusion caused by fibrohyalinosis (FH) similar to that found in CML (Brun and Englund, 1985; Ferrer et al., 1990), denervation microangiopathy (Scheibel et al., 1987) or CAA (Gray et al.,…”
BackgroundInfluentialInverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia
Goulding, J. M. R., Signorini, D. F., Chatterjee, S., Nicoll, J. A. R., Stewart, J., Morris, R. G., & Lammie, G. A. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.5.654 · Cited by 64
Neuropsychiatric Correlates of Cerebral White-Matter Radiolucencies in Probable Alzheimer's Disease
López, O. L., Becker, J. T., Rezek, D. L., Wess, J., Boiler, F., Reynolds, C. F., & Panisset, M. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530320052012 · Cited by 62 · cited 1×
“…in white matter lesions in AD White matter lesions (WML) are frequently found in AD and may or may not be correlated with cognitive decline (De la Monte, 1989; Kozachuk et al., 1990; Lopez et al., 1992; Wahlund et al., 1994; Amar et al., 1996; Kapeller and Schmidt, 1998; De Groot et al., 1998).”
BackgroundAre Alzheimer’s disease, hypertension, and cerebrocapillary damage related?☆
Farkas, E., de Vos, R. A. I., Steur, E. N. H. J., & Luiten, P. G. M. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00122-6 · Cited by 61 · cited 3×
“An additional sign of disrupted BBB in AD may be the compromised morphology of tight junctions (Claudio, 1996), whereas data on changes of microvascular pericytes are conflicting (Farkas et al., 2000).”
BackgroundMultiple Simultaneous Intracerebral Hemorrhages
Mauriño, J., Saposnik, G., Lepera, S., Rey, R. C., & Sica, R. E. P. (2001) · Archives of Neurology · doi:10.1001/archneur.58.4.629 · Cited by 59 · cited 2×
“Several recent studies described multiple simultaneous intracerebral hemorrhage associated with CAA (Hill et al., 2000; Maurino et al., 2001).”
BackgroundGuo, Z., Viitanen, M. H., & Winblad, B. G. (1997) · American Journal of Public Health · doi:10.2105/ajph.87.4.623 · Cited by 59 · cited 2×
“Low blood pressure, in line with this fact, has also been suggested to be a risk factor for AD (Passant et al., 1997; Guo et al., 1997), although other pathological mechanisms may be involved.”
BackgroundDiagnostic challenges in dementia
Kaye, J. A. (1998) · Neurology · doi:10.1212/wnl.51.1_suppl_1.s45 · Cited by 57 · cited 1×
“…degree of accuracy in the diagnosis of AD, the distinction between AD, vascular-ischemic dementia (VID), and mixed dementia (MD) (combination of AD and VID) remains controversial and has been one of the most difficult clinical and pathological challenges (Bowler and Hachinski 1998; Kaye, 1998).”
BackgroundOlichney, J., Ellis, R. J., Katzman, R., Sabbagh, M. N., & Hansen, L. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48511.x · Cited by 57 · cited 1×
“The frequency of cerebrovascular lesions increases with the severity of CAA (Olichney et al., 1997).”
BackgroundAlzheimer Disease: Mouse Models Pave the Way for Therapeutic Opportunities
Emilien, G., Maloteaux, J., Beyreuther, K. T., & Masters, C. L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.2.176 · Cited by 57 · cited 2×
“…evidence from transgenic models now indicates that mutation in the A domain of neuronal APP may predispose to a vascular pathology, whereas mutations outside the A domain lead to more neuronal pathology (Emilien et al., 2000; Grabowski et al., 2000; Holtzman et al., 2000; Masliah et al., 2001).”
BackgroundSparks, D. L., Scheff, S. W., Liu, H., Landers, T. M., Danner, F., Coyne, C. M., & Hunsaker, J. C. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00008-1 · Cited by 53 · cited 1×
“…observed in brains of non-demented individuals with coronary heart disease, often associated with ApoEε4 allele and increased cholesterol levels (Sparks et al., 1996, 1997), and increased A production has been found by increased cholesterol in both culture studies and transgenic mouse models…”
BackgroundCerebral amyloid angiopathies.
Coria, F., & Rubio, I. (1996) · PubMed · Cited by 53
Jellinger, K. A. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.520 · Cited by 37 · cited 4×
“6% with additional Lewy body pathology (Jellinger, 2001).”
BackgroundResultInfluentialSelf-citationRockwood, K. J. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297004407 · Cited by 37 · cited 1×
“It has even been questioned whether “MD” actually exists as a clinical entity, and some authors have recently recommended reevaluation and more detailed redefinition of this term (Cohen et al., 1997; Rockwood, 1997).”
BackgroundVascular changes in white matter lesions of Alzheimer's disease
Tomimoto, H., Akiguchi, I., Akiyama, H., Ikeda, K., Wakita, H., Lin, J., & Budka, H. (1999) · Acta Neuropathologica · doi:10.1007/s004010051039 · Cited by 34 · cited 5×
“limited in comparison to that of wall thickening of WM microvessels due to FH which may or may not be associated with CAA, thus indicating the pathogenetic heterogeneity of WML in AD (Tomimoto et al., 1999).”
BackgroundInfluentialAPOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage.
Nicoll, J. A. R., & McCarron, M. O. (2001) · PubMed · Cited by 27
Biggart, S., Mrcp, D. C., Fauchon, M., Cardew, G., Fou, L. D., Harker, N., Quinn, E., Keller, C., Vincent, R., & Mayne, L. V. (1998) · Clinical Cardiology · doi:10.1002/clc.4960211109 · Cited by 22 · cited 2×
“It is surprising, however, that the connection between ApoEε4 and cerebrovascular compromises had not been established given the involvement of ApoE genotype in arteriosclerosis and cardiac infarcts (Biggart et al., 1998; O’Brien et al., 1998; Snowdon et al., 1997).”
BackgroundAmyloid beta protein deposition in brains from elderly subjects with leukoaraiosis
Tabaton, M., Caponnetto, C., Mancardi, G., & Loeb, C. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90248-6 · Cited by 19 · cited 1×
“…degeneration (Leys et al., 1991) or by cerebral hypoperfusion caused by fibrohyalinosis (FH) similar to that found in CML (Brun and Englund, 1985; Ferrer et al., 1990), denervation microangiopathy (Scheibel et al., 1987) or CAA (Gray et al., 1985; Tabaton et al., 1991; Olichney et al., 1995).”
BackgroundOutcome markers for clinical trials in cerebral amyloid angiopathy.
Greenberg, S. M., & Rosand, J. M. (2001) · PubMed · Cited by 18
“Mixed Dementia”: Adequate or Antiquated?: A Critical Review
Cohen, C. I., Araujo, L., Guerrier, R., & Henry, K. A. (1997) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199700540-00002 · Cited by 16 · cited 1×
“It has even been questioned whether “MD” actually exists as a clinical entity, and some authors have recently recommended reevaluation and more detailed redefinition of this term (Cohen et al., 1997; Rockwood, 1997).”
BackgroundKa, J. (2001) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 15
Cordonnier, C., & Leys, D. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544897.062 · Cited by 12
Cerebrovascular Disease Affects Noncognitive Symptoms in Alzheimer Disease
Frisoni, G. B., & Geroldi, C. (2001) · Archives of Neurology · doi:10.1001/archneur.58.11.1939 · Cited by 9
Boström, K., & HASSLER, O. (1966) · Journal of Gerontology · doi:10.1093/geronj/21.1.97 · Cited by 8 · cited 1×
“They include looping, twining, and braiding of vessels (Boström and Hassler, 1966), periventricular venous collagenosis resulting in narrowed lumina and even occlusion (Moody et al., 1995), and vascular tortuosity often associated with white matter lesions (WML) (Brown et al., 2000), In addition,…”
Background[Neuropathology of 20 centenarians. I. Clinical data].
Fayet, G., Hauw, J., Delaère, P., He, Y., Duyckaerts, C. J., Beck, H., Forette, F., Gallinari, C., Laurent, M., & Moulias, R. (1994) · PubMed · Cited by 8
Markesbery, W. R. (1991) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199100520-00012 · Cited by 6 · cited 2×
“increase with age (Markesbery, 1991; Skoog et al., 1993), in most clinicopathologic series of demented patients, 18 to 60% of all have AD with cerebrovascular lesions (Mirra et al.”
BackgroundNon-CAA angiopathies and their possible interactions with cerebral amyloid angiopathy.
Vinter, H., & Wang, Z. (2001) · PubMed · Cited by 4
The effects of AbetaPP mutations and APOE polymorphisms on cerebral amyloid angiopathy.
Rebeck, G. W., Cho, H. S., Grabowski, T. J., & Greenberg, S. M. (2001) · PubMed · Cited by 4
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cited by
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Peters, R. (2006) · Postgraduate Medical Journal · doi:10.1136/pgmj.2005.036665 · Cited by 894
Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease
Bell, R. D., & Zlokovic, B. V. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0522-3 · Cited by 860
Alzheimer's disease: experimental models and reality
Drummond, E., & Wisniewski, T. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1662-x · Cited by 810
“Hence, the preclinical testing of therapeutic approaches in models with extensive CAA (which virtually all individuals with AD and about a third of aged cognitively normal individuals have) [68, 179] and showing that it does not induce microhemorrhages is of importance.”
BackgroundThe blood-brain barrier in Alzheimer’s disease
Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767
“Furthermore, the expression of occludin, claudin-5, and ZO-1 was strongly suppressed in the A β -laden capillaries of patients with capillary CAA, suggesting that the modulation of TJ protein expression may increase vascular permeability in the AD brain (Carrano et al., 2011; Carrano et al., 2012).”
Influential
Metadata
- Authors
- Jellinger, K. A.
- Affiliations
- Ludwig Boltzmann für Klinische Neurobiologie (AT)
- Corresponding author
- Jellinger, K. A.
- ORCID
- Jellinger, K. A.
- Venue
- Journal of Neural Transmission
- Published
- 2002-05-01
- Volume
- 109
- Issue
- 5-6
- Pages
- 813-836
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2084675121
- Cited by
- 680
- References
- 114
- Citations by year
- 2026: 7 · 2025: 25 · 2024: 32 · 2023: 19 · 2022: 38 · 2021: 32 · 2020: 22 · 2019: 26 · 2018: 23 · 2017: 22 · 2016: 30 · 2015: 44 · 2014: 38 · 2013: 27 · 2012: 39
- FWCI
- 14.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, cerebrovascular pathology, cerebral amyloid angiopathy, cerebral hemorrhage, microinfarcts, lacunes, white matter lesions, mixed dementia, vascular dementia, cognitive decline, dementia progression, blood-brain barrier dysfunction
- MeSH terms
- Alzheimer Disease, Blood Vessels, Cerebrovascular Circulation, Cerebrovascular Disorders, Diagnosis, Differential, Humans, Microcirculation, Risk Factors, Dementia, Vascular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.